TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CGEM

Cullinan Oncology LLC

Healthcare · Biotechnology

14.80$ -4.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CGEM
Line item 2012 2013 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – +0.0% -100.0% – – –
– – – – – – +62.8% -11.4% -14.5% +75.5% +233.3% -1.3% +1.6%
– – – – – – – – – -100.5% – – –
– – – – – – +75.2% +157.4% +33.6% +59.2% +61.1% -3.5% +31.1%
– -28.8% -5.2% -19.2% +106.8% +2,434.0% +9.6% +212.4% +70.2% +37.9% +5.7% +24.3% +2.7%
– – -81.6% -25.9% +106.8% +7,289.2% +52.7% +170.9% +44.0% -266.5% – +2.9% +22.9%
– – – – – – – – – – -232.1% – –
– – – – – – – – +7,270.4% +759.2% – – –
– – – – – – – – – – -211.8% – –
– – – – – – -507.3% – – – -133.5% – –
– – – – – – – – – – -237.7% – –
– – – – – – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?